Rx (Prescription Medicine)
USD $ 172.00
Docemaps 120mg Injection 是一种含有活性成分Docetaxel的药物。Docetaxel 是一种强效化疗药物，属于抗肿瘤药物的紫杉醇类。它通过干扰微管的正常功能发挥作用，微管是细胞分裂的关键组成部分。通过破坏微管的组装和解聚，Docetaxel 有效阻止快速分裂癌细胞的增殖，从而导致细胞死亡。这一机制使其成为多种癌症治疗的重要药物。Docemaps 120mg Injection 适用于包括乳腺癌、非小细胞肺癌、前列腺癌、胃腺癌和头颈部癌症在内的特定类型癌症的治疗。Docemaps 120mg Injection 的用药剂量和给药方式应严格由合格的医疗专业人员根据患者的个体情况、癌症的类型和阶段以及其对治疗的反应来确定。常见的不良反应可能包括骨髓抑制（导致血细胞计数下降）、脱发、疲劳、恶心、呕吐、腹泻和周围神经病变。出现任何不良反应应及时向医生报告。Docemaps 120mg Injection 应储存在室温（20°C至25°C或68°F至77°F），避光保存，且不应冷藏或冷冻。其给药方式为静脉注射，由医疗专业人员操作。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Docetaxel 120 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
